Bernstein Liebhard LLP Applauds Calls For Increased Scrutiny Of Transvaginal Mesh
Bernstein Liebhard LLP supports the FDA advisory panel’s calls for tougher restrictions and more clinical trials for transvaginal mesh implants, which are used to repair pelvic organ prolapse. After evaluating reports and trials on vaginal mesh complications, the panel concluded that a reclassification is appropriate. New York, NY (PRWEB) September 09, 2011 Bernstein Liebhard LLP is excited to report on the outcome of yesterday’s meeting of the Obstetrics and Gynecology Devices advisory panel to the U.S. Food and Drug Administration (“FDA”).* The advisory panel supported the FDA’s propose
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Categories
- Articles 309
- Bankruptcy 44
- Business 134
- Cases & Codes 68
- Contracts 27
- Criminal Law 122
- Employment 24
- Expert Reports 3
- Expert Witness 34
- Family Law 57
- Form Letters 15
- Immigration 3
- Intellectual Prop 32
- Internet Law 10
- Law Practice 99
- Law School 2
- Legal Research 19
- Litigation 186
- Miscellaneous 64
- PR Web 41689
- Personal Injury 608
- Press Release 43
- Probate 54
- Real Estate 68
- Tax Law 23
- Workers Comp 4